Lecanemab in Early Alzheimer’s Disease.

Lecanemab in Early Alzheimer’s Disease.

Dr. David Watson of ARTC is one of the primary author’s of this article on Lecanemab and Alzheimer’s Disease. The accumulation of soluble and insoluble aggregated amyloid-beta (Aβ) may initiate or potentiate pathologic processes in Alzheimer’s disease....